Kulkarni Uro-Surgery Institute Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 13-12-2024
- Paid Up Capital ₹ 7.00 M
as on 13-12-2024
- Company Age 9 Year, 13 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 33.50 Cr
as on 13-12-2024
- Revenue %
(FY 2022)
- Profit -258.72%
(FY 2022)
- Ebitda -196.26%
(FY 2022)
- Net Worth -2.55%
(FY 2022)
- Total Assets 121.76%
(FY 2022)
About Kulkarni Uro-Surgery Institute
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.00 M.
The company currently has active open charges totaling ₹33.50 Cr.
Sanjay Kulkarni and Jyotsna Kulkarni serve as directors at the Company.
- CIN/LLPIN
U74999PN2016PTC157827
- Company No.
157827
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jan 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kulkarni Uro-Surgery Institute?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jyotsna Kulkarni  | Director | 05-Jan-2016 | Current |
| Sanjay Kulkarni | Director | 05-Jan-2016 | Current |
Financial Performance of Kulkarni Uro-Surgery Institute.
Kulkarni Uro-Surgery Institute Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 258.72% decrease in profit. The company's net worth dipped by a decrease of 2.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kulkarni Uro-Surgery Institute?
In 2022, Kulkarni Uro-Surgery Institute had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Balwant Medical FoundationActive 4 years 9 months
Sanjay Kulkarni and Jyotsna Kulkarni are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Jul 2021 | ₹33.50 Cr | Open |
How Many Employees Work at Kulkarni Uro-Surgery Institute?
Kulkarni Uro-Surgery Institute has a workforce of 69 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kulkarni Uro-Surgery Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kulkarni Uro-Surgery Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
